Syquant Capital Sas Buys Medidata Solutions Inc, Brookfield Asset Management Inc, Genesee & Wyoming Inc, Sells Red Hat Inc, First Data Corp, Array BioPharma Inc

Author's Avatar
Oct 17, 2019
Article's Main Image
Investment company Syquant Capital Sas (Current Portfolio) buys Medidata Solutions Inc, Brookfield Asset Management Inc, Genesee & Wyoming Inc, Celgene Corp, Altaba Inc, sells Red Hat Inc, First Data Corp, Array BioPharma Inc, Control4 Corp, Pacific Biosciences of California Inc during the 3-months ended 2019Q3, according to the most recent filings of the investment company, Syquant Capital Sas. As of 2019Q3, Syquant Capital Sas owns 17 stocks with a total value of $365 million. These are the details of the buys and sells.

For the details of SYQUANT CAPITAL SAS's stock buys and sells, go to https://www.gurufocus.com/guru/syquant+capital+sas/current-portfolio/portfolio

These are the top 5 holdings of SYQUANT CAPITAL SAS
  1. Medidata Solutions Inc (MDSO) - 1,550,606 shares, 38.85% of the total portfolio. Shares added by 348.49%
  2. Celgene Corp (CELG) - 619,700 shares, 16.85% of the total portfolio. Shares added by 63.12%
  3. Brookfield Asset Management Inc (BAM) - 1,095,678 shares, 15.93% of the total portfolio. New Position
  4. Genesee & Wyoming Inc (GWR) - 458,618 shares, 13.88% of the total portfolio. New Position
  5. Altaba Inc (AABA) - 981,100 shares, 5.23% of the total portfolio. New Position
New Purchase: Brookfield Asset Management Inc (BAM)

Syquant Capital Sas initiated holding in Brookfield Asset Management Inc. The purchase prices were between $47.75 and $54.16, with an estimated average price of $50.74. The stock is now traded at around $53.40. The impact to a portfolio due to this purchase was 15.93%. The holding were 1,095,678 shares as of .

New Purchase: Genesee & Wyoming Inc (GWR)

Syquant Capital Sas initiated holding in Genesee & Wyoming Inc. The purchase prices were between $108.85 and $110.9, with an estimated average price of $110.08. The stock is now traded at around $110.83. The impact to a portfolio due to this purchase was 13.88%. The holding were 458,618 shares as of .

New Purchase: Altaba Inc (AABA)

Syquant Capital Sas initiated holding in Altaba Inc. The purchase prices were between $19.48 and $71.09, with an estimated average price of $66.23. The stock is now traded at around $19.63. The impact to a portfolio due to this purchase was 5.23%. The holding were 981,100 shares as of .

New Purchase: Monotype Imaging Holdings Inc (TYPE)

Syquant Capital Sas initiated holding in Monotype Imaging Holdings Inc. The purchase prices were between $16.16 and $20, with an estimated average price of $19.01. The stock is now traded at around $19.84. The impact to a portfolio due to this purchase was 2.08%. The holding were 384,325 shares as of .

New Purchase: Intuit Inc (INTU)

Syquant Capital Sas initiated holding in Intuit Inc. The purchase prices were between $263.19 and $292.31, with an estimated average price of $275.2. The stock is now traded at around $264.88. The impact to a portfolio due to this purchase was 1.57%. The holding were 21,600 shares as of .

New Purchase: Clorox Co (CLX)

Syquant Capital Sas initiated holding in Clorox Co. The purchase prices were between $150.23 and $166.33, with an estimated average price of $158.07. The stock is now traded at around $149.42. The impact to a portfolio due to this purchase was 1.56%. The holding were 37,400 shares as of .

Added: Medidata Solutions Inc (MDSO)

Syquant Capital Sas added to a holding in Medidata Solutions Inc by 348.49%. The purchase prices were between $90.63 and $92.01, with an estimated average price of $91.34. The stock is now traded at around $91.94. The impact to a portfolio due to this purchase was 30.19%. The holding were 1,550,606 shares as of .

Added: Celgene Corp (CELG)

Syquant Capital Sas added to a holding in Celgene Corp by 63.12%. The purchase prices were between $89.47 and $99.42, with an estimated average price of $95.04. The stock is now traded at around $101.69. The impact to a portfolio due to this purchase was 6.52%. The holding were 619,700 shares as of .

Sold Out: Red Hat Inc (RHT)

Syquant Capital Sas sold out a holding in Red Hat Inc. The sale prices were between $187.7 and $188.44, with an estimated average price of $187.88.

Sold Out: First Data Corp (FDC)

Syquant Capital Sas sold out a holding in First Data Corp. The sale prices were between $27.48 and $31.69, with an estimated average price of $28.37.

Sold Out: Array BioPharma Inc (ARRY)

Syquant Capital Sas sold out a holding in Array BioPharma Inc. The sale prices were between $46.24 and $47.85, with an estimated average price of $46.79.

Sold Out: Control4 Corp (CTRL)

Syquant Capital Sas sold out a holding in Control4 Corp. The sale prices were between $23.75 and $23.91, with an estimated average price of $23.82.

Sold Out: Pacific Biosciences of California Inc (PACB)

Syquant Capital Sas sold out a holding in Pacific Biosciences of California Inc. The sale prices were between $4.99 and $6.16, with an estimated average price of $5.6.

Sold Out: General Mills Inc (GIS)

Syquant Capital Sas sold out a holding in General Mills Inc. The sale prices were between $51.91 and $55.59, with an estimated average price of $53.9.



Here is the complete portfolio of SYQUANT CAPITAL SAS. Also check out:

1. SYQUANT CAPITAL SAS's Undervalued Stocks
2. SYQUANT CAPITAL SAS's Top Growth Companies, and
3. SYQUANT CAPITAL SAS's High Yield stocks
4. Stocks that SYQUANT CAPITAL SAS keeps buying